INTRODUCTION
============

The loss of muscle mass, strength, and function due to aging is defined as sarcopenia ([@b8-jer-14-6-1017]). Sarcopenia is a reduction of skeletal muscle mass that is associated with aging in older adults ([@b11-jer-14-6-1017]). Sarcopenia can not only lead to diminished skeletal muscles, but also to reduced mobility, an increased risk of falls and fractures, a decrease in activity related to daily living, increased medical costs, increased mortality risk, and a decrease in one's quality of life ([@b4-jer-14-6-1017]; [@b20-jer-14-6-1017]).

Because respiratory muscle strength is related to skeletal muscle mass ([@b11-jer-14-6-1017]), aging-associated alterations in the skeletal muscles can also affect the function of the respiratory muscles ([@b3-jer-14-6-1017]); as a result, sarcopenia can influence one's pulmonary function ([@b10-jer-14-6-1017]). The low pulmonary function of community-dwelling older adults is typically associated with low muscle mass ([@b11-jer-14-6-1017]). Moreover, an aging-related sedentary lifestyle can also accelerate the reduction of one's inspiratory and expiratory muscle strength ([@b3-jer-14-6-1017]).

The impairment of pulmonary function due to the weakening of respiratory muscles can cause atelectasis, ineffective cough, and other respiratory complications ([@b3-jer-14-6-1017]; [@b19-jer-14-6-1017]). These respiratory complications can lead to cardiovascular disease and all-cause mortality, as well as to bronchitis and pneumonia ([@b23-jer-14-6-1017]; [@b24-jer-14-6-1017]).

Stroke is a form of brain injury that impairs the coordination of respiratory muscles as a result of damaged motor control function ([@b9-jer-14-6-1017]). Such muscle weakness and impaired coordination lead to the reduction of respiratory function ([@b13-jer-14-6-1017]; [@b15-jer-14-6-1017]). Compared with healthy age-matched subjects, stroke patients show lower forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV~1~), peak expiratory flow (PEF), maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) ([@b14-jer-14-6-1017]; [@b13-jer-14-6-1017]; [@b26-jer-14-6-1017]). Therefore, chronic stroke patients over 60 years of age may not be able to cough effectively due to the weakening of their respiratory muscles as a result of neurological damage and aging; consequently, the prevalence of aspiration and chest infections may be heightened for this population ([@b14-jer-14-6-1017]; [@b13-jer-14-6-1017]; [@b17-jer-14-6-1017]).

The measurement of hand grip strength is a widely used method to easily measure muscle strength with a high level of reliability ([@b3-jer-14-6-1017]). Grip strength is also recommended as a simple, standardized clinical measure that can be used to diagnose sarcopenia ([@b4-jer-14-6-1017]). In addition, hand grip strength has been shown to correlate with pulmonary function and inspiratory and expiratory muscle strength ([@b5-jer-14-6-1017]; [@b8-jer-14-6-1017]; [@b11-jer-14-6-1017]; [@b24-jer-14-6-1017]). However, due to the fact that the pulmonary function test should be performed by a specialist using a medical device, it is relatively expensive.

As the age of stroke patients who spend most of their time sitting increases, their risk of developing sarcopenia increases to an even greater extent, and their pulmonary function may deteriorate to a greater extent than that of a typical older adults. As a result, this patient group requires special monitoring. Although the relationship between hand grip strength and pulmonary function has been studied in older adults and in patients with specific diseases ([@b5-jer-14-6-1017]; [@b8-jer-14-6-1017]; [@b11-jer-14-6-1017]; [@b24-jer-14-6-1017]), research on the relationship between sarcopenia and pulmonary function in aging stroke patients with a higher risk of respiratory complications is currently lacking.

The aim of this study is to investigate the relationships between grip strength and pulmonary function and respiratory muscle strength in stroke patients over 50 years of age.

MATERIALS AND METHODS
=====================

Participants
------------

This study's subjects were comprised of 51 stroke patients who had the disease for at least 6 months. The recruitment criteria for this study's subjects included the following: (a) they had experienced their first episode of unilateral stroke with hemiparesis during the previous 12 months, (b) they had sufficient unilateral upper torso and extremity nerve function and strength to accomplish arm crank ergometry, (c) they had the ability to understand and follow simple verbal instructions, and (d) they were not on any medications that would influence their metabolic or cardiorespiratory responses to exercise ([@b25-jer-14-6-1017]). The exclusion criteria included chronic pulmonary and/or cardiac disease, clinical signs of cardiac and/or respiratory disease, an impaired level of consciousness, and evidence of gross cognitive impairment ([@b25-jer-14-6-1017]).

All participants in this study received an explanation of the purpose of this study and voluntarily provided their consent to participate in this study. All protocols were approved by the Ethics Committee of the Catholic University of Pusan (CUPIRB- 2013-021).

Measurements
------------

The patients' hand grip strength was measured using a hydraulic hand dynamometer (Saehan Hydraulic Hand Dynamometer, Saehan Corp., Masan, Korea) according to the standard procedures. The hand on the nonaffected side was measured three times, and the mean value was used for the analysis. During the test, the subjects were asked to adopt a posture with the shoulder adducted and neutrally rotated, the elbow flexed to 90°, and the forearm and wrist in a neutral position. The opening of the handle was adjusted prior to testing, so that the crease of the proximal interphalangeal joints rested on the top of the adjustable handle, allowing 90° of flexion. A 30-sec break was given after every measurement ([@b5-jer-14-6-1017]; [@b18-jer-14-6-1017]).

Pulmonary function was measured using spirometry (Pony FX; COSMED Inc., Rome, Italy) according to the American Thoracic Society's guidelines ([@b1-jer-14-6-1017]). The FVC, FEV~1~, and PEF were measured as descriptions of pulmonary function. Respiratory muscle strength was measured using respiratory muscle strength measurement equipment (Pony FX MIP/MEP; COSMED Inc., Rome, Italy) according to the standards of the American Thoracic Society/European Respiratory Society ([@b2-jer-14-6-1017]). In order to produce accurate measurements, trained medical technicians provided sufficient explanations and demonstrated the method to the participants so that they could fully understand the procedure before the measurements were performed. The test was performed while each subject maintained a sitting position with a 90° flexion of the hip joint ([@b14-jer-14-6-1017]). Each subject was tested 3 times, and each subject's highest value was used as the data for the analysis.

Statistical analysis
--------------------

The collected data were analyzed using IBM SPSS Statistics ver. 22.0 (IBM Co., Armonk, NY, USA). The general characteristics, means, and standard deviations of the measured variables were analyzed via descriptive analysis. The subjects were divided into two groups according to age (50--64 years of age and over 65 years of age), and the differences in each variable between the two groups were analyzed using an independent *t*-test. The correlation between the subjects' grip strength and pulmonary function was analyzed using the Pearson correlation method. The statistical significance was set at *P*\<0.05.

RESULTS
=======

Fifty-one subjects were divided into a middle-aged group (50--64 years old) and an older adults group (65 years or older), and their general characteristics and the measured variables were compared ([Table 1](#t1-jer-14-6-1017){ref-type="table"}). There were no significant differences between the two groups---with the exception of age---with respect to the participants' sex, weight, and height.

The grip strength of the middle-aged group was significantly higher than it was for older adults group, but there was no significant difference between these values. The mean values of pulmonary function (FVC, FEV~1~, and PEF) were significantly higher in the middle-aged group than they were in older adults group (*P*\< 0.05) ([Table 1](#t1-jer-14-6-1017){ref-type="table"}). The mean values of MIP and MEP were higher in the middle-aged group than they were in older adults group, but there was no significant difference between these values.

Furthermore, the relationships between age and grip strength, pulmonary function, and respiratory muscle strength were analyzed. This analysis revealed that age showed significant negative correlations with grip strength, FVC, FEV~1~, and PEF (*P*\<0.05) ([Fig. 1](#f1-jer-14-6-1017){ref-type="fig"}), but no significant correlations between age and MIP and MEP were apparent.

In addition, the correlations between grip strength and pulmonary function and respiratory muscle strength were analyzed. Grip strength was shown to have significant positive correlations with FVC, FEV~1~, and PEF for all subjects, including subjects from both the middle-aged group and older adults group (*P*\<0.05) ([Table 2](#t2-jer-14-6-1017){ref-type="table"}). Between these two groups, the middle-aged group showed greater positive correlations with respect to FVC, FEV~1~, and PEF than older adults group.

With respect to respiratory muscle strength, there was no correlation between grip strength and MIP for all subjects, for the middle-aged group, or for older adults group; however, there was a significant positive correlation between grip strength and MEP for all subjects and for older adults group (*P*\<0.05) ([Table 2](#t2-jer-14-6-1017){ref-type="table"}).

DISCUSSION
==========

When stroke patient's age, their skeletal muscle strength tends to reduce and sarcopenia is likely to follow, which, in turn, tends to influence their respiratory muscle strength as well. In this study, the subjects were divided into two age groups in order to investigate the correlation between the patients' pulmonary function and age-related sarcopenia in stroke patients with respiratory muscle weakness due to hemiplegia.

As muscle strength of older adults is related not only to age but also to sex, height, and weight ([@b8-jer-14-6-1017]), a homogeneity test was performed to determine whether there were any intergroup differences---irrespective of age---in the sex, height, weight, and body mass index of the two groups; no significant difference was discovered.

The present study aimed to investigate the relationships between grip strength and pulmonary function and respiratory muscle strength in older adults. Consistent with a previous report that the lung function of disabled, older women was reduced due to their decreased physical performance ([@b22-jer-14-6-1017]), the pulmonary function of the subjects in this study, who were stroke patients with reduced physical activity due to hemiplegia, was also lower than that of the normal control group ([@b11-jer-14-6-1017]). When the pulmonary function of community-dwelling older men and women aged 71--73 years on average was compared according to their sarcopenia status, it was found that FVC was significantly higher in the group without sarcopenia, but no significant difference in FEV~1~ was found between the two groups ([@b11-jer-14-6-1017]). Similarly, when community-dwelling older women with sarcopenia (aged 75.4±5.3 years on average) and community-dwelling older women without sarcopenia (aged 73.0±6.2 years on average) were compared, it was found that the left and right grip strength and FVC were significantly higher in the group without sarcopenia; however, no significant difference was found with respect to FEV~1~, PEF, MIP, and MEP ([@b10-jer-14-6-1017]). Also, in the present study, the middle-aged group whose grip strength was higher than that of older adults group---although there was no significant difference---displayed significantly higher FEV~1~ and PEF, as well as significantly higher FVC, in comparison to that of older adults group. This finding---that there were significant differences in FEV~1~ and PEF between the two groups---suggests that there is a significant correlation between age and pulmonary function ([@b11-jer-14-6-1017]).

It has been shown that the height-adjusted strength of community-dwelling older men was positively correlated with FVC (*r*=0.206, *P*=0.001) and FEV~1~ (*r*=0.315, *P*=0.001) ([@b11-jer-14-6-1017]). Similarly, the hand grip strength of the general population (at an average age of 56.4 years) was reported to have positive correlations with FVC (*r*=0.76, *P*=0.001) and FEV~1~ (*r*=0.69, *P*=0.001) ([@b12-jer-14-6-1017]). In addition, it was shown that the higher the FVC and FEV~1~ of apparently healthy community-dwelling older women over 65 years of age, the greater their hand grip strength, suggesting that hand grip strength is positively correlated with FVC and FEV~1~ ([@b24-jer-14-6-1017]). In the present study conducted with stroke patients, grip strength was found to have positive correlations with FVC, FEV~1~, and PEF for both the middle-aged group and older adults group. This result indicates that aging-related reduction in the subjects' skeletal muscle mass resulted in the reduction of these patients' respiratory muscle mass and strength ([@b7-jer-14-6-1017]), ultimately leading to reduce pulmonary function.

In particular, FVC showed a higher level of correlation than FEV~1~, which can be explained by the fact that, while FVC is mainly influenced by respiratory muscle strength, FEV~1~ is influenced not only by respiratory muscle strength, but also by the patient's airway status ([@b24-jer-14-6-1017]). Consistent with this finding, FVC showed a higher correlation with grip strength than FEV~1~ in the present study conducted with stroke patients. This can be attributed to the fact that restrictive pulmonary disease caused by decreased respiratory muscle function as a result of neurological damage is more common in stroke patients than obstructive pulmonary disease in which the airway becomes narrow.

When the relationship between grip strength and lung function was investigated in older in-patients aged over 85 years on average, there was a significant positive correlation between grip strength and FEV~1~ in older men, and the grip strength of older women had significant positive correlations with slow vital capacity and PEF ([@b8-jer-14-6-1017]). In the same study, respiratory muscle strength was not measured; however, both the older men and women showed correlations with FEV~1~ and PEF, which are closely associated with expiratory muscle strength. Another study reported that the grip strength of male nursing home residents was only positively correlated with peak cough flow among other pulmonary function items (*r*=0.34, *P*\<0.01) ([@b3-jer-14-6-1017]). The grip strength of older patients and older adults living in nursing homes, who have a more sedentary lifestyle than typical older adults, showed relatively low correlations with FVC. Similarly, the results of the present study also showed that the correlation between grip strength and FVC was slightly lower for older adults group in comparison to that of the middle-aged group.

This relationship between grip strength and pulmonary function suggests that an aging-related decrease in pulmonary function is manifested as a loss of muscle mass and that sarcopenia can be predicted by the extent of a patient's relative decrease in pulmonary function ([@b11-jer-14-6-1017]). In the present study conducted with stroke patients, the level of pulmonary function was significant as an indicator in the prediction of the extent of sarcopenia, as the correlation levels of grip strength with FVC or FEV~1~ were 0.5 or higher.

The relationship between age and maximal static respiratory pressures was unclear in a cross-sectional study, but many studies have suggested that MEP and MIP are associated with peripheric muscle strength indicating sarcopenia along with age in reduced respiratory muscle performance ([@b6-jer-14-6-1017]). However, in the present study, no significant relationships were found between age and MIP and MEP.

Sarcopenia of respiratory muscles such as the diaphragm has not yet been discovered, but an aging-related decrease in respiratory muscle strength is referred to as sarcopenia of the respiratory muscles ([@b7-jer-14-6-1017]). Since physical activity plays an important role in maintaining inspiratory and expiratory muscle strength, a sedentary lifestyle, in addition to aging, can reduce inspiratory and expiratory muscle strength ([@b16-jer-14-6-1017]). In addition to aging, sarcopenia of respiratory muscles can contribute to respiratory complications ([@b7-jer-14-6-1017]). The stroke patients who participated in the present study had a more sedentary lifestyle than the typical older adults, and the MIP and MEP of both older adults group and the middle-aged group were lower than the MIP (52.9±15.4) and MEP (48.4±13.5) obtained from typical older women without sarcopenia and the MIP (50.3± 17.1) and MEP (50.3±18.8) obtained from typical older women with sarcopenia ([@b10-jer-14-6-1017]). Although there was no significant difference between these levels, the older adults group had even lower MIP and MEP levels than the middle-aged group. These results suggest that stroke patients tend to spend more time sitting than the general older adults, due to difficulties in physical activity as a result of hemiplegia, and that their respiratory muscle function was also decreased due to damage to their nervous system. These results also suggest that they are likely to be at greater risk for respiratory complications than the general older adults.

Low MIP and normal MEP levels indicate a weakening of the diaphragmatic muscle---a main inspiratory muscle---whereas low MIP and MEP levels indicate a weakening of the overall skeletal muscles ([@b3-jer-14-6-1017]). Therefore, MEP can act as a sensitive indicator of deterioration of the respiratory muscle as patients with neuromuscular disease age ([@b21-jer-14-6-1017]). In a study conducted in a subject group of apparently healthy older women, MIP and MEP were positively correlated with hand grip strength ([@b24-jer-14-6-1017]). However, in the present study conducted with stroke patients who had experienced nervous system damage, their MIP and MEP levels were lower than those of the general older adults; this is indicative of overall muscle reduction, and a significant correlation was found only between hand grip strength and MEP.

The limitations of this study are that the homogeneity of sex, which could affect the results of the study, was statistically obtained, as the analysis could not be performed with respect to sex due to the small number of subjects. In order to generalize the results of the present study, it is necessary to conduct a similar study using a larger number of subjects in consideration of sex.

This study showed that stroke patients over 50 years of age had decreased grip strength, pulmonary function, MIP, and MEP, in comparison with the general older adults, and that grip strength is correlated with pulmonary function and MEP. Therefore, it is necessary to apply muscular strengthening exercise to prevent sarcopenia and to monitor pulmonary function using grip strength test in older stroke patients.
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###### 

Participant characteristics and their pulmonary function and grip strength

  Characteristic       Total (n=51)   Middle age (n=18)   Older adults (n=33)   *t/χ*^2^   *P*-value
  -------------------- -------------- ------------------- --------------------- ---------- -----------------------------------------------------
  Sex, male:female     18±27          9:9                 12:21                 0.894      0.344
  Age (yr)             68.69±10.40    58.11±3.94          75.36±6.36            −10.430    0.000[\*](#tfn3-jer-14-6-1017){ref-type="table-fn"}
  Weight (kg)          60.88±10.60    61.75±9.54          61.00±10.99           0.244      0.809
  Height (cm)          159.51±8.53    161.78±9.38         158.69±7.77           1.257      0.215
  Grip strength (kg)   22.34±8.55     23.35±9.62          20.56±7.61            1.138      0.261
  FVC (L)              1.96±0.49      2.21±0.46           1.77±0.42             3.470      0.001[\*](#tfn3-jer-14-6-1017){ref-type="table-fn"}
  FEV~1~ (L)           1.57±0.48      1.90±0.47           1.34±0.33             4.933      0.000[\*](#tfn3-jer-14-6-1017){ref-type="table-fn"}
  FEV~1~/FVC           80.52±13.46    86.53±10.42         76.57±12.90           2.807      0.007[\*](#tfn3-jer-14-6-1017){ref-type="table-fn"}
  PEF (L/min)          2.87±1.40      3.58±1.71           2.34±0.85             2.871      0.009[\*](#tfn3-jer-14-6-1017){ref-type="table-fn"}
  MIP (cmH~2~O)        28.56±10.51    31.17±12.68         26.90±8.83            1.406      0.166
  MEP (cmH~2~O)        30.98±9.81     33.83±8.62          29.03±10.17           1.696      0.096

Values are presented as mean±standard deviation.

FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 sec; PEF, peak expiratory flow; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure.

*P*\<0.05, significantly different between middle age and older adults groups.

###### 

The correlation between grip strength and pulmonary function and respiratory muscle strength

  Group                 FVC                                                     FEV~1~                                                  PEF                                                     MIP     MEP
  --------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------- -------------------------------------------------------
  Total (n=51)          0.686[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.607[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.494[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.239   0.348[\*](#tfn5-jer-14-6-1017){ref-type="table-fn"}
  Middle age (n=18)     0.812[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.764[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.598[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.150   0.071
  Older adults (n=33)   0.613[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.521[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}   0.345[\*](#tfn5-jer-14-6-1017){ref-type="table-fn"}     0.277   0.477[\*\*](#tfn6-jer-14-6-1017){ref-type="table-fn"}

FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 sec; PEF, peak expiratory flow; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure.

*P*\<0.05.

*P*\<0.01.
